Cargando…

Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps

Political momentum and funding for combatting antimicrobial resistance (AMR) continues to build. Numerous major international and national initiatives aimed at financially incentivising the research and development (R&D) of antibiotics have been implemented. However, it remains unclear how to ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simpkin, Victoria L, Renwick, Matthew J, Kelly, Ruth, Mossialos, Elias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746591/ https://www.ncbi.nlm.nih.gov/pubmed/29089600 http://dx.doi.org/10.1038/ja.2017.124

Ejemplares similares

Challenges and opportunities for incentivising antibiotic research and development in Europe
por: Anderson, Michael, et al.
Publicado: (2023)

A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics
por: Renwick, Matthew J, et al.
Publicado: (2016)

Improving health evaluations to capture wider value of therapeutics and incentivise innovation
por: Chan, Mei Sum, et al.
Publicado: (2023)

Investing in health R&D: where we are, what limits us, and how to make progress in Africa
por: Simpkin, Victoria, et al.
Publicado: (2019)

Plenary Talk: Incentivising Open Science
por: Díaz, Maria Camila
Publicado: (2023)

Cost-effectiveness of cancer drugs: Comparative analysis of the United States and England
por: Cherla, Avi, et al.
Publicado: (2020)

Effect of financial incentives on incentivised and non-incentivised clinical activities: longitudinal analysis of data from the UK Quality and Outcomes Framework
por: Doran, Tim, et al.
Publicado: (2011)

Effect of financial incentives on incentivised and non-incentivised clinical activities: longitudinal analysis of data from the UK Quality and Outcomes Framework
Publicado: (2013)

Human ventromedial prefrontal lesions alter incentivisation by reward
por: Manohar, Sanjay G., et al.
Publicado: (2016)

Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
por: Kobashi, Yurie, et al.
Publicado: (2019)

Incentivising research data sharing: a scoping review
por: Woods, Helen Buckley, et al.
Publicado: (2022)

Incentivising open ecological data using blockchain technology
por: Lewis, Robert John, et al.
Publicado: (2023)

Cost‐Effectiveness of Cardiovascular, Obesity, and Diabetes Mellitus Drugs: Comparative Analysis of the United States and England
por: Cherla, Avi, et al.
Publicado: (2020)

Incentives for new antibiotics: the Options Market for Antibiotics (OMA) model
por: Brogan, David M, et al.
Publicado: (2013)

Structural equation model for estimating risk factors in type 2 diabetes mellitus in a Middle Eastern setting: evidence from the STEPS Qatar
por: Roman-Urrestarazu, Andres, et al.
Publicado: (2016)

Group Health Coaching: Strengths, Challenges, and Next Steps
por: Armstrong, Colin, et al.
Publicado: (2013)

Anti-trypanosomatid drug discovery: progress and challenges
por: De Rycker, Manu, et al.
Publicado: (2022)

Deuterium in drug discovery: progress, opportunities and challenges
por: Di Martino, Rita Maria Concetta, et al.
Publicado: (2023)

Dataset for multidimensional assessment to incentivise decentralised energy investments in Sub-Saharan Africa
por: Bender, A., et al.
Publicado: (2021)

Antimicrobial resistance: progress and challenges in antibiotic discovery and anti‐infective therapy
por: Krell, Tino, et al.
Publicado: (2021)

Drug repositioning: Progress and challenges in drug discovery for various diseases
por: Hua, Yi, et al.
Publicado: (2022)

Target discovery for T cell therapy: next steps to advance Immunotherapies
por: Bot, Adrian, et al.
Publicado: (2015)

Antibiotic drug discovery
por: Wohlleben, Wolfgang, et al.
Publicado: (2016)

Trial to Incentivise Adherence for Diabetes (TRIAD): study protocol for a randomised controlled trial
por: Bilger, Marcel, et al.
Publicado: (2017)

Developing the latest framework to measure and incentivise pharmaceutical industry contributions to health research and development
por: Cole, Clarke B., et al.
Publicado: (2018)

Incentivisation practices and their influence on physicians’ prescriptions: A qualitative analysis of practice and policy in Pakistan
por: Khan, Mishal, et al.
Publicado: (2023)

BioChainReward: A Secure and Incentivised Blockchain Framework for Biomedical Data Sharing
por: Elkhodr, Mahmoud, et al.
Publicado: (2023)

A blockchain-based information market to incentivise cooperation in swarms of self-interested robots
por: Van Calck, Ludéric, et al.
Publicado: (2023)

Polio eradication: next steps and future challenges
por: Zambon, Maria, et al.
Publicado: (2018)

Digital mental health: challenges and next steps
por: Smith, Katharine A, et al.
Publicado: (2023)

Challenges and recent progress in drug discovery for tropical diseases
por: De Rycker, Manu, et al.
Publicado: (2018)

Challenges and opportunities for continued access to effective antibiotics - what role for the EU?
por: Anderson, M, et al.
Publicado: (2023)

1873. Next Steps in Predicting Anti-MRSA Antibiotic Prescribing
por: Holmer, Haley K, et al.
Publicado: (2018)

Inverse design with deep generative models: next step in materials discovery
por: Lu, Shuaihua, et al.
Publicado: (2022)

Assessing the acceptability of incentivising HPV vaccination consent form return as a means of increasing uptake
por: Rockliffe, Lauren, et al.
Publicado: (2018)

Incentivising use of structured language in biological descriptions: Author-driven phenotype data and ontology production
por: Cui, Hong, et al.
Publicado: (2018)

Strategy, Progress, and Challenges of Drug Repurposing for Efficient Antiviral Discovery
por: Li, Xinlei, et al.
Publicado: (2021)

Shaping the next steps of research on frailty: challenges and opportunities
por: Aprahamian, Ivan, et al.
Publicado: (2021)

Innovation Experiences from Africa-Led Drug Discovery at the Holistic Drug Discovery and Development (H3D) Centre
por: Singh, Vinayak, et al.
Publicado: (2022)

Three Innovations of Next-Generation Antibiotics: Evolvability, Specificity, and Non-Immunogenicity
por: Shim, Hyunjin
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dosnp0gjhhqq3gm1orpci33pb8